A Landmark Achievement: Robo Medical’s Endoscopic Robot Approved for the Chinese Market
In a groundbreaking development for medical technology, the National Medical Products Administration (NMPA) of China has granted market approval to Robo Medical for its Control Device for Digestive Endoscopic Surgical Instruments. The approval, which came on March 11, 2025, marks the device as the world’s first surgical robot specifically designed for digestive endoscopy to receive market authorization.
The approval addresses long-standing challenges in the treatment of early-stage digestive cancers, a field historically marked by high technical difficulty, extensive learning curves, and reliance on individual surgical skill. Traditional endoscopic surgeries can lead to longer operation times and increased complication risks due to the lack of precise assistive tools. In addition, existing surgical robots have been limited by high costs and a lack of compatibility with conventional endoscopes.
Robo Medical’s new system tackles these issues with an innovative, externally-mounted flexible robotic arm. Utilizing a master-slave control mode, it provides precise, four-degree-of-freedom movement, enabling surgeons to achieve flexible control over instrument gripping and direction to improve visibility of the surgical field. The product’s simple design ensures it is compatible with various brands of traditional endoscopes without requiring structural modifications.
This technology is expected to advance the level of early cancer screening and minimally invasive treatment in China, ultimately benefiting a broader patient population worldwide.
Disclaimer: The information on this platform is for informational purposes only and is based on publicly available sources, such as official press releases and regulatory databases. While we strive for accuracy, details may vary from the manufacturer’s official statements, particularly if they have been translated. We encourage readers to consult the manufacturer’s official website and communications for the most current and accurate information. This report is not a substitute for professional medical advice, diagnosis, or treatment and does not constitute an endorsement of any product or company. We do not accept responsibility for any errors, omissions, or actions taken based on the information provided.